Matches in Wikidata for { <http://www.wikidata.org/entity/Q47992122> ?p ?o ?g. }
- Q47992122 description "2012 nî lūn-bûn" @default.
- Q47992122 description "2012年の論文" @default.
- Q47992122 description "2012年学术文章" @default.
- Q47992122 description "2012年学术文章" @default.
- Q47992122 description "2012年学术文章" @default.
- Q47992122 description "2012年学术文章" @default.
- Q47992122 description "2012年学术文章" @default.
- Q47992122 description "2012年学术文章" @default.
- Q47992122 description "2012年學術文章" @default.
- Q47992122 description "2012年學術文章" @default.
- Q47992122 description "2012年學術文章" @default.
- Q47992122 description "2012年學術文章" @default.
- Q47992122 description "2012年學術文章" @default.
- Q47992122 description "2012년 논문" @default.
- Q47992122 description "article científic" @default.
- Q47992122 description "article scientific" @default.
- Q47992122 description "article scientifique" @default.
- Q47992122 description "articol științific" @default.
- Q47992122 description "articolo scientifico" @default.
- Q47992122 description "artigo científico" @default.
- Q47992122 description "artigo científico" @default.
- Q47992122 description "artigo científico" @default.
- Q47992122 description "artikel ilmiah" @default.
- Q47992122 description "artikull shkencor" @default.
- Q47992122 description "artikulong pang-agham" @default.
- Q47992122 description "artykuł naukowy" @default.
- Q47992122 description "artículo científico publicado en 2012" @default.
- Q47992122 description "artículu científicu" @default.
- Q47992122 description "bilimsel makale" @default.
- Q47992122 description "bài báo khoa học" @default.
- Q47992122 description "naučni članak" @default.
- Q47992122 description "scienca artikolo" @default.
- Q47992122 description "scientific article published on 21 March 2012" @default.
- Q47992122 description "scientific article published on 21 March 2012" @default.
- Q47992122 description "scientific article published on 21 March 2012" @default.
- Q47992122 description "teaduslik artikkel" @default.
- Q47992122 description "tieteellinen artikkeli" @default.
- Q47992122 description "tudományos cikk" @default.
- Q47992122 description "vedecký článok" @default.
- Q47992122 description "vetenskaplig artikel" @default.
- Q47992122 description "videnskabelig artikel" @default.
- Q47992122 description "vitenskapelig artikkel" @default.
- Q47992122 description "vitskapeleg artikkel" @default.
- Q47992122 description "vědecký článek" @default.
- Q47992122 description "wetenschappelijk artikel" @default.
- Q47992122 description "wissenschaftlicher Artikel" @default.
- Q47992122 description "επιστημονικό άρθρο" @default.
- Q47992122 description "мақолаи илмӣ" @default.
- Q47992122 description "наукова стаття, опублікована в березні 2012" @default.
- Q47992122 description "научна статия" @default.
- Q47992122 description "научная статья" @default.
- Q47992122 description "научни чланак" @default.
- Q47992122 description "научни чланак" @default.
- Q47992122 description "מאמר מדעי" @default.
- Q47992122 description "مقالة علمية نشرت في 21 مارس 2012" @default.
- Q47992122 description "২১ মার্চ ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q47992122 description "บทความทางวิทยาศาสตร์" @default.
- Q47992122 description "სამეცნიერო სტატია" @default.
- Q47992122 name "Rationale and design of MARQUEE: a phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancer." @default.
- Q47992122 name "Rationale and design of MARQUEE: a phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancer." @default.
- Q47992122 type Item @default.
- Q47992122 label "Rationale and design of MARQUEE: a phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancer." @default.
- Q47992122 label "Rationale and design of MARQUEE: a phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancer." @default.
- Q47992122 prefLabel "Rationale and design of MARQUEE: a phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancer." @default.
- Q47992122 prefLabel "Rationale and design of MARQUEE: a phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancer." @default.
- Q47992122 P1433 Q47992122-0B3BCEAF-432E-4553-B57C-3D17A017647B @default.
- Q47992122 P1476 Q47992122-284E0658-1125-48DB-AA28-1E4299EB0C18 @default.
- Q47992122 P2093 Q47992122-12726B6F-EBE5-400E-AFDE-01C0E08D3F12 @default.
- Q47992122 P2093 Q47992122-28478BA0-200D-4AFF-8911-77CD3D9CDE86 @default.
- Q47992122 P2093 Q47992122-409D56D7-1A3D-436B-BC86-82BE65D0F76E @default.
- Q47992122 P2093 Q47992122-6B2BEF2C-54DC-4CCD-9552-B7579470679A @default.
- Q47992122 P2093 Q47992122-70D51C83-5940-48EF-8C44-AC6105345BC4 @default.
- Q47992122 P2093 Q47992122-BBC3EFF8-001D-4C4A-82C0-12023AF88B0B @default.
- Q47992122 P2093 Q47992122-E05482BD-C572-4EC7-83F6-D9CBBDCE43B2 @default.
- Q47992122 P2093 Q47992122-ED7F53DD-15F6-41AE-BABC-513C75DFDA90 @default.
- Q47992122 P2860 Q47992122-FE335A5C-D01C-444D-B467-BA6D0D102E6B @default.
- Q47992122 P304 Q47992122-31D9AA31-F513-4694-81E9-6ACE7111C317 @default.
- Q47992122 P31 Q47992122-A0BF0F17-2B92-4C05-98BD-5CA3A0F0BF53 @default.
- Q47992122 P356 Q47992122-47FE3623-F339-45C7-8753-4BF3978E3105 @default.
- Q47992122 P407 Q47992122-E02C0337-9B48-42C9-8531-BED9DEB64BFC @default.
- Q47992122 P433 Q47992122-1319D853-D6E0-4319-8019-C1F9D130BA9A @default.
- Q47992122 P478 Q47992122-F09CA541-C010-4971-ACA7-411A1A99514B @default.
- Q47992122 P50 Q47992122-908D31C1-74EC-4838-AE62-535F9FF3E122 @default.
- Q47992122 P50 Q47992122-BD6EC86E-89B1-442E-B8D3-AB35C2F2CC6A @default.
- Q47992122 P577 Q47992122-189770A7-BAF4-4433-AADD-A1B5AFA7F119 @default.
- Q47992122 P698 Q47992122-3A1E5BD0-5263-4DAF-B815-29DBC649C9E8 @default.
- Q47992122 P921 Q47992122-0D8EB3D1-CD6F-4E7B-A3F1-6A4E780D4258 @default.
- Q47992122 P921 Q47992122-EA0F8C73-D005-46A4-8420-25D4FBC5BB25 @default.
- Q47992122 P356 J.CLLC.2012.01.003 @default.
- Q47992122 P698 22440336 @default.
- Q47992122 P1433 Q332299 @default.
- Q47992122 P1476 "Rationale and design of MARQUEE: a phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancer." @default.
- Q47992122 P2093 "Alan B Sandler" @default.
- Q47992122 P2093 "Brian Schwartz" @default.
- Q47992122 P2093 "Giorgio V Scagliotti" @default.
- Q47992122 P2093 "Joachim von Pawel" @default.
- Q47992122 P2093 "Joan H Schiller" @default.
- Q47992122 P2093 "Reinhard Von Roemeling" @default.
- Q47992122 P2093 "Silvia Novello" @default.
- Q47992122 P2093 "Vera Hirsh" @default.